메타프리즈

메타프리즈 is a declared insider of 웰바이오텍, with filings sourced from DART (FSS). In total, 28 filings cover trades dated from 15 February 2021 to 21 January 2026.

Every open-market trade on record is a purchase: 28 purchases, and no sale. The amount is not disclosed for 28 filings. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. In 2026 alone, the filings show 1 purchase and no sales.

No cluster: in 28 purchases, no other insider of the company bought within 30 days.

The latest filing, published on 27 January 2026, reports an open-market purchase in 웰바이오텍. Typically, a trade is published a median of 7 days after it takes place. This delay matters because a trade only becomes useful information once it is public. Every figure here comes from the filings published by DART (FSS) and describes the past, not future prices; it is not investment advice.